What Kennedy’s Approach to Addiction Gets Wrongnews2024-12-22T12:40:41+00:00December 22nd, 2024|The New York Times|
El medicamento innovador para vencer la adicción: ¿Ozempic?news2024-11-06T10:40:06+00:00November 6th, 2024|The New York Times|
Why We May Soon Use Ozempic to Treat Addictionnews2024-10-18T12:20:09+00:00October 18th, 2024|The New York Times|
F.D.A. Approves a New Antipsychotic Drugnews2024-09-27T14:36:45+00:00September 27th, 2024|The New York Times|
First Day of a ‘New Life’ for a Boy With Sickle Cellnews2024-09-16T18:49:38+00:00September 16th, 2024|The New York Times|
Broken Again. A National Advocate for Drug Recovery Relapses.news2024-09-07T09:00:36+00:00September 7th, 2024|The New York Times|
FDA Declines to Approve MDMA Therapy, and Seeks Further Studynews2024-08-10T11:56:53+00:00August 10th, 2024|The New York Times|
Veterans and Lawmakers Lobby for Approval of MDMA Therapynews2024-08-08T22:01:37+00:00August 8th, 2024|The New York Times|
FDA Panel Rejects Use of MDMA for Treatment of PTSDnews2024-06-04T23:06:17+00:00June 4th, 2024|The New York Times|
Why PTSD Is So Hard to Diagnose and Treatnews2024-06-04T22:00:17+00:00June 4th, 2024|The New York Times|